In summary, bacterial suspensions containing the microorganism Lactobacillus casei Shirota (Yakult Brasil Ltda, Lot # 0758) were used in the experiments. This strain was chosen because it is a bacterial species that poses no risk of environmental contamination and measures 0.5 μm (the SARS-CoV-2 virus measures 0.1 μm). Additionally, this microorganism has already been tested and validated for the dispersion model in a dental clinic environment in a previous study [8]. Thus, a viability test was performed to determine the initial concentration of 1.5x108 CFU / mL of L. casei Shirota, based on the study by Marthi et al. [17].

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.